As one of the latest weight loss peptides, Retatrutide’s triple receptor activation has attracted the attention of many Semaglutide users and Tirzpatide users. At the same time, like Semaglutide, it acts on GLP-1 receptors, and like Tirzpatide, it acts on GLP-1 receptors and GIP receptors. As a result, users tend to experience fewer side effects when they switch to Retatrutide, …